{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:57:45Z","timestamp":1772035065353,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI137332-01"],"award-info":[{"award-number":["R01 AI137332-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104905","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T11:43:27Z","timestamp":1597232607000},"page":"104905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-9615","authenticated-orcid":false,"given":"Wendy S.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine H.","family":"Schein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104905_bib1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.vaccine.2018.12.071","article-title":"Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs","volume":"37","author":"Abente","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01309462","article-title":"Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection","volume":"139","author":"Agapov","year":"1994","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104905_bib4","series-title":"F1000Research 6","article-title":"Cardiovascular Involvement and Manifestations of Systemic Chikungunya Virus Infection: A Systematic Review","author":"Alvarez","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104905_bib5","doi-asserted-by":"crossref","first-page":"e0207406","DOI":"10.1371\/journal.pone.0207406","article-title":"Atypical and severe manifestations of chikungunya virus infection in French Guiana: a hospital-based study","volume":"13","author":"Bonifay","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104905_bib6","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.vaccine.2012.07.042","article-title":"Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes","volume":"30","author":"Bowen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib72","article-title":"D-graph clusters flaviviruses and beta-coronaviruses according to their hosts, disease type and human cell receptors","author":"Braun","year":"2020","journal-title":"BioRxiv"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104905_bib7","doi-asserted-by":"crossref","first-page":"e02325","DOI":"10.1128\/AAC.02325-18","article-title":"Src family kinase inhibitors block translation of alphavirus subgenomic mRNAs","volume":"63","author":"Broeckel","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104905_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2019.01.015","article-title":"New World alphavirus protein interactomes from a therapeutic perspective","volume":"163","author":"Carey","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104905_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJMoa1212628","article-title":"Eastern equine encephalitis in Latin America","volume":"369","author":"Carrera","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104905_bib10","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmb.2009.11.070","article-title":"PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype","volume":"396","author":"Danecek","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104905_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1504\/IJBRA.2010.032117","article-title":"Flavitrack analysis of the structure and function of West Nile non-structural proteins","volume":"6","author":"Danecek","year":"2010","journal-title":"Int. J. Bioinf. Res. Appl."},{"key":"10.1016\/j.antiviral.2020.104905_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.coviro.2012.02.014","article-title":"Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives","volume":"2","author":"Dupuy","year":"2012","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.antiviral.2020.104905_bib14","first-page":"8521060","author":"Dupuy","year":"2018","journal-title":"Journal of immunology research"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104905_bib15","doi-asserted-by":"crossref","first-page":"e01274","DOI":"10.1128\/JVI.01274-17","article-title":"Novel insect-specific eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge","volume":"92","author":"Erasmus","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib16","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy","volume":"88","author":"Fong","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib17","doi-asserted-by":"crossref","first-page":"e0005693","DOI":"10.1371\/journal.pntd.0005693","article-title":"Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas","volume":"11","author":"Forrester","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104905_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104905_bib19","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1016\/j.vaccine.2016.09.044","article-title":"Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus","volume":"34","author":"Friedrich","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-17","article-title":"Antibody preparations from human transchromosomic cows exhibit prophylactic and therapeutic efficacy against Venezuelan equine encephalitis virus","volume":"91","author":"Gardner","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib21","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib22","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1128\/JVI.75.14.6303-6309.2001","article-title":"An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross river virus to utilize heparan sulfate as an attachment moiety","volume":"75","author":"Heil","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib23","doi-asserted-by":"crossref","first-page":"e37398","DOI":"10.1371\/journal.pone.0037398","article-title":"Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity","volume":"7","author":"Karki","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104905_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virusres.2014.11.011","article-title":"A naturally occurring substitution in the E2 protein of Salmonid alphavirus subtype 3 changes viral fitness","volume":"196","author":"Karlsen","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104905_bib25","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1128\/JVI.73.12.10440-10446.1999","article-title":"A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats","volume":"73","author":"Kobiler","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib26","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1038\/s41598-018-32033-w","article-title":"Lipid-coated mesoporous silica nanoparticles for the delivery of the ML336 antiviral to inhibit encephalitic alphavirus infection","volume":"8","author":"LaBauve","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104905_bib27","doi-asserted-by":"crossref","first-page":"e0005189","DOI":"10.1371\/journal.pntd.0005189","article-title":"Molecular virologic and clinical characteristics of a chikungunya fever outbreak in La romana, Dominican republic, 2014","volume":"10","author":"Langsjoen","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104905_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(14)60185-9","article-title":"Chikungunya in the americas","volume":"383","author":"Leparc-Goffart","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104905_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.antiviral.2020.104905_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2018.03.022","article-title":"Distinguishing allergens from non-allergenic homologues using Physical-Chemical Property (PCP) motifs","volume":"99","author":"Lu","year":"2018","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104905_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/v9100279","article-title":"Venezuelan equine encephalitis virus capsid-the clever caper","volume":"9","author":"Lundberg","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104905_bib32","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1128\/JVI.00948-16","article-title":"Single-site glycoprotein mutants inhibit a late event in sindbis virus assembly","volume":"90","author":"Magliocca","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(87)90135-7","article-title":"Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra","volume":"167","author":"Manavalan","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2020.104905_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4269\/ajtmh.14-0543","article-title":"Genetic diversity of Venezuelan alphaviruses and circulation of a Venezuelan equine encephalitis virus subtype IAB strain during an interepizootic period","volume":"93","author":"Medina","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2020.104905_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1051\/vetres:2004019","article-title":"Equine viral vaccines: the past, present and future","volume":"35","author":"Minke","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2020.104905_bib36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/bioinformatics\/btm383","article-title":"Flavitrack: an annotated database of flavivirus sequences","volume":"23","author":"Misra","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2020.104905_bib37","doi-asserted-by":"crossref","first-page":"e60427","DOI":"10.1371\/journal.pone.0060427","article-title":"Molecular determinants of mouse neurovirulence and mosquito infection for western equine encephalitis virus","volume":"8","author":"Mossel","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104905_bib38","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.antiviral.2020.104905_bib71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00894-006-0101-7","article-title":"Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus","volume":"12","author":"Negi","year":"2006","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.antiviral.2020.104905_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molimm.2020.03.017","article-title":"Epitopes with similar physicochemical properties contribute to cross reactivity between peanut and tree nuts","volume":"122","author":"Nesbit","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104905_bib40","doi-asserted-by":"crossref","first-page":"e0004630","DOI":"10.1371\/journal.pntd.0004630","article-title":"Chikungunya fever cases identified in the veterans health administration system","volume":"10","author":"Perti","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104905_bib41","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104905_bib42","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib44","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1128\/JVI.01286-14","article-title":"Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies","volume":"88","author":"Porta","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/JVI.02364-15","article-title":"Structural studies of chikungunya virus-like particles complexed with human antibodies: neutralization and cell-to-cell transmission","volume":"90","author":"Porta","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104905_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nbt984","article-title":"Cold-shock induced high-yield protein production in Escherichia coli","volume":"22","author":"Qing","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104905_bib47","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2012.09.049","article-title":"Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis","volume":"30","author":"Reisler","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib48","doi-asserted-by":"crossref","first-page":"e0003797","DOI":"10.1371\/journal.pntd.0003797","article-title":"IRES-containing VEEV vaccine protects cynomolgus macaques from IE Venezuelan equine encephalitis virus aerosol challenge","volume":"9","author":"Rossi","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104905_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0958-1669(91)90046-8","article-title":"Optimizing protein folding to the native state in bacteria","volume":"2","author":"Schein","year":"1991","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104905_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0958-1669(93)90012-L","article-title":"Solubility and secretability","volume":"4","author":"Schein","year":"1993","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104905_bib51","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nbt0704-826","article-title":"A cool way to make proteins","volume":"22","author":"Schein","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104905_bib52","series-title":"Encyclopedia of Industrial Biotechnology:Bioprocess, Bioseparation, and Cell Technology","article-title":"Soluble protein expression in bacteria","author":"Schein","year":"2010"},{"key":"10.1016\/j.antiviral.2020.104905_bib53","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2105-13-S13-S9","article-title":"Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals","volume":"13","author":"Schein","year":"2012","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.antiviral.2020.104905_bib54","first-page":"291","article-title":"Formation of soluble recombinant proteins in Escherichia coli is favored by lower growth temperature","volume":"6","author":"Schein","year":"1988","journal-title":"Bio Technol."},{"key":"10.1016\/j.antiviral.2020.104905_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2015.05.016","article-title":"Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses","volume":"484","author":"Schein","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104905_bib56","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/jm300214e","article-title":"Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis","volume":"55","author":"Sindac","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104905_bib57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2020.104905_bib58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.omtm.2020.04.009","article-title":"Nanoplasmid vectors Co-expressing innate immune agonists enhance DNA vaccines for Venezuelan equine encephalitis virus and ebola virus","volume":"17","author":"Suschak","year":"2020","journal-title":"Molecular therapy. Methods & clinical development"},{"key":"10.1016\/j.antiviral.2020.104905_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fmicb.2017.00081","article-title":"Live, attenuated Venezuelan equine encephalitis virus vaccine (TC83) causes persistent brain infection in mice with non-functional alphabeta T-cells","volume":"8","author":"Taylor","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104905_bib60","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/14760584.2014.944168","article-title":"Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses?","volume":"13","author":"Trobaugh","year":"2014","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib61","doi-asserted-by":"crossref","first-page":"e6835","DOI":"10.1371\/journal.pone.0006835","article-title":"Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes","volume":"4","author":"Tsetsarkin","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104905_bib62","doi-asserted-by":"crossref","first-page":"e1487913","DOI":"10.1080\/2162402X.2018.1487913","article-title":"Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens","volume":"7","author":"van de Wall","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.antiviral.2020.104905_bib63","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00894-001-0058-5","article-title":"New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical-chemical properties","volume":"7","author":"Venkatarajan","year":"2001","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.antiviral.2020.104905_bib64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104905_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prot.20676","article-title":"The protein circular dichroism data bank (PCDDB): a bioinformatics and spectroscopic resource","volume":"62","author":"Wallace","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2020.104905_bib66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.vaccine.2017.12.046","article-title":"Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins","volume":"36","author":"Wang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104905_bib67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2012.04.002","article-title":"Alphaviruses: population genetics and determinants of emergence","volume":"94","author":"Weaver","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104905_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003684","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"9","author":"Weber","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2020.104905_bib69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4269\/ajtmh.14-0055","article-title":"Current strategic thinking for the development of a trivalent alphavirus vaccine for human use","volume":"91","author":"Wolfe","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2020.104905_bib70","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1038\/emboj.2011.261","article-title":"4.4 \u00c5 cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO J."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:59Z","timestamp":1759062839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":72,"alternative-id":["S0166354220303193"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104905","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104905"}}